Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Armata Pharmaceuticals (ARMP) Return on Sales (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Return on Sales for 6 consecutive years, with 3.4% as the latest value for Q4 2018.

  • Quarterly Return on Sales fell 23930.0% to 3.4% in Q4 2018 from the year-ago period, while the trailing twelve-month figure was 11.07% through Dec 2018, up 6103.0% year-over-year, with the annual reading at 4.55% for FY2025, 500.0% down from the prior year.
  • Return on Sales hit 3.4% in Q4 2018 for Armata Pharmaceuticals, down from 9.03% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 242.7% in Q4 2017 to a low of 230.75% in Q2 2017.
  • Historically, Return on Sales has averaged 40.33% across 5 years, with a median of 31.78% in 2014.
  • Biggest five-year swings in Return on Sales: surged 73255bps in 2014 and later tumbled -23930bps in 2018.
  • Year by year, Return on Sales stood at 25.71% in 2014, then grew by 13bps to 22.4% in 2015, then tumbled by -650bps to 168.09% in 2016, then surged by 244bps to 242.7% in 2017, then crashed by -99bps to 3.4% in 2018.
  • Business Quant data shows Return on Sales for ARMP at 3.4% in Q4 2018, 9.03% in Q3 2018, and 11.27% in Q2 2018.